TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | -1 | 21 | -4 | -13 | -39 | -68 | -17 |
| P | %wins | 67 | 100 | 67 | 33 | 0 | 0 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/17 17:53 | 11/8/16 | PBYA | Probility Media Corp | NV | BizSv | EngSv | Engineering, Accounting, Rese | Levine Evan | TX | DO | CEO | P | 3,942 | 0.8000 | 0 | 4,928 | 180 | 7,672 | D | ||||||||||||||
4/15/08 17:14 | 2/8/08 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Levine Evan | CA | DO | CEO,P | P | 3 | 0.5060 | 0 | 5 | 0 | 4,395 | D | -90 | -80 | -34 | 15 | -20 | -2 | -10 | -6 | 0 | 9 | 2 | -23 | -55 | -62 |
4/15/08 17:12 | 10/4/04 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Levine Evan | CA | DO | CEO,P | P.m | 40 | 1.59 | 0 | 25 | 1 | 4,390 | D | -90 | -80 | -34 | 15 | -20 | -2 | -10 | -6 | 0 | 9 | 2 | -23 | -55 | -62 |
12/17/07 12:16 | 12/14/07 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Levine Evan | CA | DO | CEO,Dir | P | 27 | 0.4467 | 0 | 60 | 1 | 4,380 | D | -84 | -81 | -82 | -79 | -20 | 4 | 0 | 2 | -2 | 44 | -15 | 8 | -8 | -79 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |